Fuller & Thaler Asset Management Inc. Has $74.60 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Fuller & Thaler Asset Management Inc. reduced its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 18.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,215,433 shares of the company's stock after selling 729,203 shares during the quarter. Fuller & Thaler Asset Management Inc. owned 1.89% of Option Care Health worth $74,598,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. Pinebridge Investments L.P. increased its holdings in shares of Option Care Health by 42.7% in the fourth quarter. Pinebridge Investments L.P. now owns 61,059 shares of the company's stock valued at $1,417,000 after purchasing an additional 18,265 shares during the last quarter. Dark Forest Capital Management LP bought a new position in shares of Option Care Health during the fourth quarter worth approximately $1,178,000. Hsbc Holdings PLC lifted its holdings in Option Care Health by 14.4% during the 4th quarter. Hsbc Holdings PLC now owns 13,681 shares of the company's stock worth $315,000 after purchasing an additional 1,727 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in Option Care Health by 174.4% in the 4th quarter. Tower Research Capital LLC TRC now owns 11,142 shares of the company's stock valued at $258,000 after purchasing an additional 7,082 shares during the period. Finally, MetLife Investment Management LLC grew its holdings in Option Care Health by 7.8% in the 4th quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after buying an additional 14,311 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Price Performance

Shares of OPCH stock opened at $32.14 on Thursday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The business has a fifty day simple moving average of $33.33 and a 200 day simple moving average of $28.70. The company has a market cap of $5.28 billion, a P/E ratio of 27.01, a P/E/G ratio of 2.30 and a beta of 1.07.

Insider Activity

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.64% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. Barrington Research reissued an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Monday. Jefferies Financial Group upgraded shares of Option Care Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research report on Thursday, March 6th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Finally, JMP Securities reiterated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Tuesday. Two analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $33.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.